Correction: In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

Correction for ‘In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling’ by Thamer A. Alsubi et al., RSC Adv., 2020, 10, 22668–22683, DOI: 10.1039/D0RA01624A.

Detalles Bibliográficos
Autores principales: Alsubi, Thamer A., Attwa, Mohamed W., Bakheit, Ahmed H., Darwish, Hany W., Abuelizz, Hatem A., Kadi, Adnan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055114/
https://www.ncbi.nlm.nih.gov/pubmed/35532509
http://dx.doi.org/10.1039/d0ra90070b
Descripción
Sumario:Correction for ‘In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling’ by Thamer A. Alsubi et al., RSC Adv., 2020, 10, 22668–22683, DOI: 10.1039/D0RA01624A.

Ejemplares similares